Publication | Closed Access

ITIH4 Serum Concentration Increases during Acute-Phase Processes in Human Patients and Is Up-Regulated by Interleukin-6 in Hepatocarcinoma HepG2 Cells

InflammationCytokineHepatologyAutoimmune DiseaseHepatocellular CarcinomaLiver PhysiologyImmunologyHepatitisPathologyAutoimmunityAcute-phase ProcessesHepatotoxicityLiver CancerItih4 Serum ConcentrationMedicineTumor MicroenvironmentHuman Patients